News Releases

Statement regarding testimony on HB 248

AOA leadership responds to recent testimony on HB 248 at the Ohio House of Representatives.

By AOA President and AOA CEO


Statement attributable to AOA President Thomas L. Ely, DO, and AOA CEO Kevin Klauer, DO, EJD

On June 9, the American Osteopathic Association became aware of the June 8 testimony provided by Sherri Tenpenny, DO, at the Ohio House of Representatives hearing on House Bill 248, the Enact Vaccine Choice and Anti-Discrimination Act.

Following careful review of the reported testimony, we find the statements included material misinformation, personal perspectives without support of evidence or scientific foundation, and are not consistent with the principles and practice of osteopathic medicine.

We support collegial debate based on professional differences of opinion on the appraisal of scientific literature. However, creating fear from non-scientific opinion without evidence is irresponsible, unconscionable, and undermines the public trust in the receipt of safe and efficacious medical care.

The AOA urges all Americans to get the COVID 19 vaccine. This vaccine is a scientific achievement that has saved countless lives. We strongly support the evidence affirming the safety of vaccine technology and reject unsubstantiated claims to the contrary.

This matter is under further review and will be carefully and thoroughly considered by the American Osteopathic Association.